VOYA Investment Management
AGRX

VOYA Investment Management’s Agile Therapeutics AGRX Stock Holding History

VOYA Investment Management’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16
Closed -$67K – 2928
2021
Q1 		$67K Hold
16
– – ﹤0.01% 2721
2020
Q4 		$92K Buy
16
+4
+33% +$23.5K ﹤0.01% 2573
2020
Q3 		$73K Hold
12
– – ﹤0.01% 2394
2020
Q2 		$66K Buy
+12
New +$62.4K ﹤0.01% 2406

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VOYA Investment Management's AGRX Position: Q2 2021 in Review

VOYA Investment Management sold out of Agile Therapeutics (AGRX) in Q2 2021, closing a stake of 16 shares — an estimated $67K sold.

VOYA Investment Management first reported a position in AGRX in Q2 2020 and held it in 4 quarters. The position peaked at $92K in Q4 2020. 64 funds tracked by Wall St. Rank hold AGRX as of Q2 2021.

  • VOYA Investment Management reported no remaining Agile Therapeutics position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 16 Agile Therapeutics shares in Q2 2021, an estimated $67K.
  • VOYA Investment Management first reported a position in Agile Therapeutics in Q2 2020 and held it in 4 quarters.
  • VOYA Investment Management's Agile Therapeutics position peaked at $92K in Q4 2020.
  • 64 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.